Vertex Pharmaceuticals (VRTX)Susquehanna Portfolio Strategies, LLC added to its stake +62K shares

91K

Shares reported · +62K vs prior quarter

0.72%

Disclosed portfolio weight

$45.2M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed purchase of VRTX — reported range $1,001 - $15,000
2. Jun 15, 2026InsiderOfficer sold ~$1.83M of VRTX shares in the open market
3. Jun 18, 2026InsiderOfficer sold ~$471K of VRTX shares in the open market
4. Jun 26, 2026InsiderOfficer sold ~$288K of VRTX shares in the open market
5. Jul 1, 2026InsiderOfficer sold ~$416K of VRTX shares in the open market
6. Jul 2, 2026Insider · 2 peopleInsiders: 2 sales (~$1.6M)
7. Jul 6, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
8. Aug 3, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Aug 26, 2026CongressDisclosed sale of VRTX — reported range $1,001 - $15,000
2. Aug 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 27, 2026, Vertex Pharmaceuticals Incorporated (the “Company”) appointed Jonathan Poole as Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2027 (the “Effective Date”).”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Vertex Pharmaceuticals

For Vertex Pharmaceuticals, OQRO holds 2 Congress trade reports and 42 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRTX page.

How this filing works

• SEC Form 13F

Other disclosures at Vertex Pharmaceuticals

• House Clerk periodic transaction reportSep 5, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its VRTX page.